Atlas Trials

Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS

Clinical trial NCT03852459 · COMPLETED

Trial details

NCT number
NCT03852459
Sponsor
Aponia Laboratories, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pain, Acute
Start date
2018-01-12
Primary completion
2019-04-04
Enrollment
251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.